| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 3.19e-10 | 20 | 93 | 6 | GO:0061665 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 3.21e-09 | 50 | 93 | 7 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 4.89e-09 | 53 | 93 | 7 | GO:0016859 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 1.51e-08 | 36 | 93 | 6 | GO:0019789 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD4 RGPD2 RANBP2 RGPD8 MYCBP2 DOCK8 RGPD3 RGPD1 SIPA1L2 RHOF DIS3 ASAP1 RGPD5 | 6.37e-07 | 507 | 93 | 13 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD4 RGPD2 RANBP2 RGPD8 MYCBP2 DOCK8 RGPD3 RGPD1 SIPA1L2 RHOF DIS3 ASAP1 RGPD5 | 6.37e-07 | 507 | 93 | 13 | GO:0030695 |
| GeneOntologyMolecularFunction | isomerase activity | 3.20e-06 | 192 | 93 | 8 | GO:0016853 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 6.16e-06 | 279 | 93 | 9 | GO:0005096 | |
| GeneOntologyMolecularFunction | small GTPase binding | 1.89e-05 | 321 | 93 | 9 | GO:0031267 | |
| GeneOntologyMolecularFunction | GTPase binding | 4.62e-05 | 360 | 93 | 9 | GO:0051020 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 9.97e-05 | 398 | 93 | 9 | GO:0061659 | |
| GeneOntologyMolecularFunction | GDP binding | 1.20e-04 | 103 | 93 | 5 | GO:0019003 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | RGPD4 MED20 RGPD2 RANBP2 RGPD8 MYCBP2 HECTD3 RGPD3 RGPD1 SHPRH | 1.35e-04 | 512 | 93 | 10 | GO:0019787 |
| GeneOntologyMolecularFunction | G protein activity | 1.65e-04 | 59 | 93 | 4 | GO:0003925 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | RGPD4 MED20 RGPD2 RANBP2 RGPD8 MYCBP2 HECTD3 RGPD3 RGPD1 SHPRH | 1.85e-04 | 532 | 93 | 10 | GO:0016755 |
| GeneOntologyMolecularFunction | GTPase activity | 1.92e-04 | 341 | 93 | 8 | GO:0003924 | |
| GeneOntologyMolecularFunction | acyltransferase activity | RGPD4 MED20 RGPD2 RANBP2 RGPD8 BRCA2 MYCBP2 HECTD3 RGPD3 AGPAT2 RGPD1 SHPRH | 2.50e-04 | 775 | 93 | 12 | GO:0016746 |
| GeneOntologyMolecularFunction | fatty acid binding | 3.02e-04 | 69 | 93 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | GTP binding | 5.32e-04 | 397 | 93 | 8 | GO:0005525 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | 1.02e-03 | 439 | 93 | 8 | GO:0032561 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | 1.02e-03 | 439 | 93 | 8 | GO:0019001 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 1.58e-03 | 107 | 93 | 4 | GO:0033293 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | RGPD4 RGPD2 RANBP2 RGPD8 MYCBP2 DOCK8 RGPD3 RGPD1 SERPING1 SIPA1L2 RHOF DIS3 ASAP1 SORL1 RGPD5 | 2.24e-03 | 1418 | 93 | 15 | GO:0030234 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.95e-03 | 127 | 93 | 4 | GO:0008094 | |
| GeneOntologyMolecularFunction | long-chain fatty acid transmembrane transporter activity | 3.13e-03 | 18 | 93 | 2 | GO:0005324 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RAB10 ERCC3 BRIP1 RAP2A RAP2B CRACR2A GNAT1 RAP2C RHOF RAB3C | 3.24e-03 | 775 | 93 | 10 | GO:0017111 |
| GeneOntologyMolecularFunction | cadherin binding involved in cell-cell adhesion | 3.49e-03 | 19 | 93 | 2 | GO:0098641 | |
| GeneOntologyMolecularFunction | enzyme activator activity | 3.49e-03 | 656 | 93 | 9 | GO:0008047 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 5.93e-13 | 9 | 93 | 6 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 1.48e-12 | 10 | 93 | 6 | GO:1903301 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 2.22e-12 | 20 | 93 | 7 | GO:0006607 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 1.19e-11 | 13 | 93 | 6 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 2.08e-11 | 14 | 93 | 6 | GO:1903299 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 3.39e-10 | 38 | 93 | 7 | GO:0000413 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 4.49e-09 | 54 | 93 | 7 | GO:0018208 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 3.17e-08 | 71 | 93 | 7 | GO:0006111 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 1.47e-07 | 132 | 93 | 8 | GO:0043255 | |
| GeneOntologyBiologicalProcess | gluconeogenesis | 6.99e-07 | 111 | 93 | 7 | GO:0006094 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 8.89e-07 | 115 | 93 | 7 | GO:0019319 | |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 1.25e-06 | 121 | 93 | 7 | GO:0046364 | |
| GeneOntologyBiologicalProcess | carbohydrate biosynthetic process | 1.76e-06 | 247 | 93 | 9 | GO:0016051 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 2.48e-06 | 134 | 93 | 7 | GO:0010906 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | RGPD4 RAB10 RGPD2 TTBK2 IFT140 RANBP2 WAPL RGPD8 BRCA2 VPS13C RGPD3 RGPD1 SIX4 ASAP1 TULP2 SORL1 RGPD5 | 6.70e-06 | 1091 | 93 | 17 | GO:0033365 |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | RGPD4 RGPD2 RANBP2 RAP2A RAP2B RGPD8 CD244 PTPRJ RGPD3 RGPD1 CAMTA1 RAP2C LEPR FABP3 TPD52L1 | 8.62e-06 | 879 | 93 | 15 | GO:0045937 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | RGPD4 RGPD2 RANBP2 RAP2A RAP2B RGPD8 CD244 PTPRJ RGPD3 RGPD1 CAMTA1 RAP2C LEPR FABP3 TPD52L1 | 8.62e-06 | 879 | 93 | 15 | GO:0010562 |
| GeneOntologyBiologicalProcess | regulation of carbohydrate metabolic process | 9.85e-06 | 231 | 93 | 8 | GO:0006109 | |
| GeneOntologyBiologicalProcess | RNA transport | 1.44e-05 | 175 | 93 | 7 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 1.44e-05 | 175 | 93 | 7 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 1.61e-05 | 178 | 93 | 7 | GO:0051236 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 1.70e-05 | 249 | 93 | 8 | GO:0015931 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | RGPD4 RAB10 RGPD2 RANBP2 RGPD8 BRCA2 VPS13C RGPD3 RGPD1 SORL1 RGPD5 | 2.03e-05 | 515 | 93 | 11 | GO:0072594 |
| GeneOntologyBiologicalProcess | nuclear export | 2.06e-05 | 185 | 93 | 7 | GO:0051168 | |
| GeneOntologyBiologicalProcess | intracellular protein transport | RGPD4 RAB10 RGPD2 RANBP2 RGPD8 COPA XPO5 VPS13C RGPD3 RGPD1 ICE1 SORL1 RGPD5 | 2.71e-05 | 740 | 93 | 13 | GO:0006886 |
| GeneOntologyBiologicalProcess | protein import into nucleus | 2.89e-05 | 195 | 93 | 7 | GO:0006606 | |
| GeneOntologyBiologicalProcess | Rap protein signal transduction | 3.12e-05 | 14 | 93 | 3 | GO:0032486 | |
| GeneOntologyBiologicalProcess | intracellular transport | RGPD4 RAB10 RGPD2 IFT140 RANBP2 AFTPH CRACR2A RGPD8 COPA XPO5 VPS13C RGPD3 RGPD1 ICE1 ERGIC2 INPP4B FABP3 SORL1 RGPD5 | 3.24e-05 | 1496 | 93 | 19 | GO:0046907 |
| GeneOntologyBiologicalProcess | import into nucleus | 3.51e-05 | 201 | 93 | 7 | GO:0051170 | |
| GeneOntologyBiologicalProcess | mRNA transport | 5.02e-05 | 145 | 93 | 6 | GO:0051028 | |
| GeneOntologyBiologicalProcess | nuclear transport | 5.26e-05 | 378 | 93 | 9 | GO:0051169 | |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | 5.26e-05 | 378 | 93 | 9 | GO:0006913 | |
| GeneOntologyBiologicalProcess | RNA localization | 5.70e-05 | 217 | 93 | 7 | GO:0006403 | |
| GeneOntologyBiologicalProcess | regulation of kinase activity | RGPD4 RGPD2 RANBP2 SLC8A3 RAP2B RGPD8 PTPRJ RGPD3 RGPD1 RAP2C FABP4 TPD52L1 | 5.90e-05 | 686 | 93 | 12 | GO:0043549 |
| GeneOntologyBiologicalProcess | glucose metabolic process | 1.19e-04 | 244 | 93 | 7 | GO:0006006 | |
| GeneOntologyBiologicalProcess | protein folding | 1.25e-04 | 246 | 93 | 7 | GO:0006457 | |
| GeneOntologyBiologicalProcess | regulation of small molecule metabolic process | 1.50e-04 | 434 | 93 | 9 | GO:0062012 | |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | RGPD4 RGPD2 RANBP2 SLC8A3 RAP2A RAP2B RGPD8 CD244 PTPRJ RGPD3 RGPD1 CAMTA1 RAP2C LEPR FABP4 FABP3 TPD52L1 | 1.86e-04 | 1421 | 93 | 17 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | RGPD4 RGPD2 RANBP2 SLC8A3 RAP2A RAP2B RGPD8 CD244 PTPRJ RGPD3 RGPD1 CAMTA1 RAP2C LEPR FABP4 FABP3 TPD52L1 | 1.89e-04 | 1423 | 93 | 17 | GO:0051174 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | RGPD4 RGPD2 RANBP2 RAP2A RAP2B RGPD8 PTPRJ RGPD3 RGPD1 RAP2C LEPR TPD52L1 | 1.97e-04 | 780 | 93 | 12 | GO:0042327 |
| GeneOntologyBiologicalProcess | protein retention in Golgi apparatus | 1.99e-04 | 5 | 93 | 2 | GO:0045053 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | 2.32e-04 | 362 | 93 | 8 | GO:0034504 | |
| GeneOntologyBiologicalProcess | microvillus assembly | 2.68e-04 | 28 | 93 | 3 | GO:0030033 | |
| GeneOntologyBiologicalProcess | regulation of transferase activity | RGPD4 RGPD2 RANBP2 SLC8A3 RAP2B RGPD8 PTPRJ RGPD3 RGPD1 RAP2C FABP4 TPD52L1 | 2.79e-04 | 810 | 93 | 12 | GO:0051338 |
| GeneOntologyBiologicalProcess | positive regulation of protein autophosphorylation | 2.98e-04 | 29 | 93 | 3 | GO:0031954 | |
| GeneOntologyBiologicalProcess | hexose metabolic process | 3.01e-04 | 284 | 93 | 7 | GO:0019318 | |
| GeneOntologyBiologicalProcess | regulation of synaptic assembly at neuromuscular junction | 4.16e-04 | 7 | 93 | 2 | GO:0008582 | |
| GeneOntologyBiologicalProcess | microvillus organization | 4.80e-04 | 34 | 93 | 3 | GO:0032528 | |
| GeneOntologyBiologicalProcess | monosaccharide metabolic process | 5.08e-04 | 310 | 93 | 7 | GO:0005996 | |
| GeneOntologyBiologicalProcess | carbohydrate metabolic process | 6.61e-04 | 646 | 93 | 10 | GO:0005975 | |
| GeneOntologyBiologicalProcess | regulation of neuromuscular junction development | 8.84e-04 | 10 | 93 | 2 | GO:1904396 | |
| GeneOntologyBiologicalProcess | synaptic assembly at neuromuscular junction | 1.08e-03 | 11 | 93 | 2 | GO:0051124 | |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | RGPD4 RGPD2 RANBP2 SLC8A3 RAP2A RAP2B RGPD8 PTPRJ RGPD3 RGPD1 RAP2C LEPR FABP4 TPD52L1 | 1.15e-03 | 1226 | 93 | 14 | GO:0042325 |
| GeneOntologyBiologicalProcess | regulation of protein autophosphorylation | 1.17e-03 | 46 | 93 | 3 | GO:0031952 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 1.83e-13 | 8 | 93 | 6 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 1.36e-12 | 10 | 93 | 6 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 1.92e-11 | 14 | 93 | 6 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 1.17e-10 | 18 | 93 | 6 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 2.43e-10 | 20 | 93 | 6 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 3.39e-10 | 21 | 93 | 6 | GO:0106068 | |
| GeneOntologyCellularComponent | nuclear pore | 3.36e-07 | 101 | 93 | 7 | GO:0005643 | |
| GeneOntologyCellularComponent | inclusion body | 3.04e-06 | 90 | 93 | 6 | GO:0016234 | |
| GeneOntologyCellularComponent | nuclear membrane | 3.50e-06 | 349 | 93 | 10 | GO:0031965 | |
| GeneOntologyCellularComponent | nuclear envelope | RGPD4 CPTP RGPD2 RANBP2 BRIP1 PHF20 RGPD8 CD38 RGPD3 RGPD1 SORL1 RGPD5 | 7.03e-06 | 560 | 93 | 12 | GO:0005635 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | RGPD4 RAB10 RGPD2 RANBP2 SLC8A3 AFTPH RGPD8 HECTD3 RGPD3 RGPD1 CKAP4 PPIB RAB3C TPD52L1 SORL1 | 1.51e-05 | 934 | 93 | 15 | GO:0048471 |
| GeneOntologyCellularComponent | secretory granule membrane | 1.60e-05 | 329 | 93 | 9 | GO:0030667 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RGPD4 MED20 RGPD2 ELOB FANCB RANBP2 ERCC3 BRIP1 PHF20 RGPD8 BRCA2 RGPD3 RGPD1 ICE1 RBM47 DIS3 RGPD5 | 1.09e-04 | 1377 | 93 | 17 | GO:0140513 |
| GeneOntologyCellularComponent | recycling endosome membrane | 1.44e-04 | 112 | 93 | 5 | GO:0055038 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | CPTP RAB10 RAP2A RAP2B AFTPH COPA PTPRJ VPS13C AGPAT2 CKAP4 FRMPD3 LY96 RAP2C RHOF RAB3C SORL1 | 1.96e-04 | 1307 | 93 | 16 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | CPTP RAB10 RAP2A RAP2B AFTPH COPA PTPRJ VPS13C AGPAT2 CKAP4 FRMPD3 LY96 RAP2C RHOF RAB3C SORL1 | 2.29e-04 | 1325 | 93 | 16 | GO:0012506 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | RGPD4 CPTP RAB10 RGPD2 RANBP2 SLC8A3 RGPD8 COPA VPS13C RGPD3 AGPAT2 RGPD1 CKAP4 ERGIC2 GRIN3A SORL1 | 2.33e-04 | 1327 | 93 | 16 | GO:0042175 |
| GeneOntologyCellularComponent | secretory granule | RAB10 RAP2B CRACR2A BRCA2 PTPRJ VPS13C AGPAT2 SERPING1 CKAP4 FRMPD3 RAP2C RHOF DERA | 5.39e-04 | 1014 | 93 | 13 | GO:0030141 |
| GeneOntologyCellularComponent | specific granule membrane | 7.30e-04 | 91 | 93 | 4 | GO:0035579 | |
| GeneOntologyCellularComponent | specific granule | 7.46e-04 | 160 | 93 | 5 | GO:0042581 | |
| GeneOntologyCellularComponent | transferase complex | RGPD4 MED20 RGPD2 ELOB RANBP2 ERCC3 DCAF13 PHF20 RGPD8 BRCA2 RGPD3 RGPD1 | 1.14e-03 | 963 | 93 | 12 | GO:1990234 |
| GeneOntologyCellularComponent | secretory vesicle | RAB10 RAP2B CRACR2A BRCA2 PTPRJ VPS13C AGPAT2 SERPING1 CKAP4 FRMPD3 RAP2C RHOF RAB3C DERA | 1.18e-03 | 1246 | 93 | 14 | GO:0099503 |
| GeneOntologyCellularComponent | organelle envelope | RGPD4 CPTP RGPD2 RANBP2 SLC8A3 BRIP1 PHF20 RGPD8 MRS2 VPS13C CD38 RGPD3 RGPD1 SORL1 RGPD5 | 1.61e-03 | 1435 | 93 | 15 | GO:0031967 |
| GeneOntologyCellularComponent | recycling endosome | 3.15e-03 | 222 | 93 | 5 | GO:0055037 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 1.06e-10 | 16 | 71 | 6 | MP:0003701 | |
| MousePheno | decreased tumor latency | 1.19e-10 | 30 | 71 | 7 | MP:0010308 | |
| MousePheno | abnormal tumor latency | 3.11e-10 | 34 | 71 | 7 | MP:0010307 | |
| MousePheno | abnormal morula morphology | 2.94e-09 | 26 | 71 | 6 | MP:0012058 | |
| MousePheno | failure of blastocyst formation | 9.22e-09 | 31 | 71 | 6 | MP:0012129 | |
| MousePheno | abnormal blastocyst formation | 3.96e-08 | 39 | 71 | 6 | MP:0012128 | |
| MousePheno | abnormal chromosome morphology | 2.30e-07 | 126 | 71 | 8 | MP:0003702 | |
| MousePheno | abnormal cell nucleus morphology | 3.60e-07 | 184 | 71 | 9 | MP:0003111 | |
| MousePheno | aneuploidy | 6.17e-07 | 61 | 71 | 6 | MP:0004024 | |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 1.12e-06 | 107 | 71 | 7 | MP:0003694 | |
| MousePheno | increased hepatocellular carcinoma incidence | 1.40e-06 | 70 | 71 | 6 | MP:0003331 | |
| MousePheno | abnormal blastocyst hatching | 1.62e-06 | 113 | 71 | 7 | MP:0003693 | |
| MousePheno | abnormal eye electrophysiology | 2.16e-06 | 228 | 71 | 9 | MP:0005551 | |
| MousePheno | abnormal rod electrophysiology | 2.30e-06 | 119 | 71 | 7 | MP:0004021 | |
| MousePheno | abnormal preimplantation embryo development | 2.35e-06 | 171 | 71 | 8 | MP:0009781 | |
| MousePheno | increased lung carcinoma incidence | 2.67e-06 | 78 | 71 | 6 | MP:0008714 | |
| MousePheno | embryonic lethality before implantation | 3.52e-06 | 242 | 71 | 9 | MP:0006204 | |
| MousePheno | abnormal mitosis | 3.74e-06 | 128 | 71 | 7 | MP:0004046 | |
| MousePheno | abnormal chromosome number | 4.73e-06 | 86 | 71 | 6 | MP:0004023 | |
| MousePheno | increased carcinoma incidence | 6.72e-06 | 197 | 71 | 8 | MP:0002038 | |
| MousePheno | abnormal incidence of induced tumors | 8.31e-06 | 269 | 71 | 9 | MP:0013151 | |
| MousePheno | embryonic lethality before implantation, complete penetrance | 8.37e-06 | 203 | 71 | 8 | MP:0011094 | |
| MousePheno | enlarged epididymis | 1.07e-05 | 99 | 71 | 6 | MP:0004931 | |
| MousePheno | increased sarcoma incidence | 1.27e-05 | 102 | 71 | 6 | MP:0002032 | |
| MousePheno | increased respiratory system tumor incidence | 1.67e-05 | 107 | 71 | 6 | MP:0010298 | |
| MousePheno | increased lung tumor incidence | 1.67e-05 | 107 | 71 | 6 | MP:0008014 | |
| MousePheno | abnormal intracellular organelle morphology | RGPD4 RAB10 RGPD2 RANBP2 BRIP1 CTNNAL1 RGPD8 BRCA2 MRS2 RGPD3 RGPD1 TULP2 | 1.74e-05 | 546 | 71 | 12 | MP:0014239 |
| MousePheno | increased hepatobiliary system tumor incidence | 2.06e-05 | 111 | 71 | 6 | MP:0010297 | |
| MousePheno | increased liver tumor incidence | 2.06e-05 | 111 | 71 | 6 | MP:0008019 | |
| MousePheno | increased malignant tumor incidence | 2.57e-05 | 237 | 71 | 8 | MP:0002018 | |
| MousePheno | increased incidence of tumors by chemical induction | 7.91e-05 | 141 | 71 | 6 | MP:0004499 | |
| MousePheno | abnormal preimplantation embryo morphology | 9.01e-05 | 283 | 71 | 8 | MP:0014137 | |
| MousePheno | impaired glucose tolerance | 1.46e-04 | 480 | 71 | 10 | MP:0005293 | |
| MousePheno | decreased susceptibility to diet-induced obesity | 1.59e-04 | 160 | 71 | 6 | MP:0005659 | |
| MousePheno | abnormal epididymis size | 1.94e-04 | 166 | 71 | 6 | MP:0004926 | |
| MousePheno | increased incidence of induced tumors | 2.42e-04 | 173 | 71 | 6 | MP:0002021 | |
| MousePheno | increased Sertoli cell number | 2.52e-04 | 5 | 71 | 2 | MP:0002776 | |
| MousePheno | decreased susceptibility to weight gain | 3.58e-04 | 186 | 71 | 6 | MP:0010182 | |
| MousePheno | abnormal epididymis morphology | 4.20e-04 | 269 | 71 | 7 | MP:0002631 | |
| MousePheno | short femur | 4.61e-04 | 127 | 71 | 5 | MP:0003109 | |
| MousePheno | embryonic lethality prior to organogenesis, complete penetrance | RGPD4 MED20 RAB10 RGPD2 RANBP2 ERCC3 DCAF13 RGPD8 BRCA2 RGPD3 EIF2S2 RGPD1 | 4.66e-04 | 772 | 71 | 12 | MP:0014259 |
| MousePheno | increased energy expenditure | 4.73e-04 | 196 | 71 | 6 | MP:0004889 | |
| MousePheno | embryonic lethality prior to tooth bud stage, complete penetrance | RGPD4 MED20 RAB10 RGPD2 RANBP2 ERCC3 DCAF13 RGPD8 BRCA2 RGPD3 EIF2S2 RGPD1 | 5.06e-04 | 779 | 71 | 12 | MP:0014257 |
| MousePheno | decreased femur size | 5.13e-04 | 130 | 71 | 5 | MP:0030825 | |
| MousePheno | abnormal glucose tolerance | RGPD4 RGPD2 DPP4 RANBP2 RGPD8 VPS13C CD38 RGPD3 AGPAT2 RGPD1 DIS3 LEPR | 5.54e-04 | 787 | 71 | 12 | MP:0005291 |
| MousePheno | increased classified tumor incidence | 6.72e-04 | 381 | 71 | 8 | MP:0010273 | |
| MousePheno | abnormal classified tumor incidence | 7.08e-04 | 384 | 71 | 8 | MP:0020188 | |
| MousePheno | abnormal femur morphology | 7.51e-04 | 214 | 71 | 6 | MP:0000559 | |
| MousePheno | abnormal hindlimb stylopod morphology | 7.69e-04 | 215 | 71 | 6 | MP:0003856 | |
| MousePheno | small testis | RGPD4 RGPD2 FANCB RANBP2 BRIP1 RGPD8 BRCA2 FBXW12 RGPD3 AGPAT2 EIF2S2 RGPD1 | 8.23e-04 | 823 | 71 | 12 | MP:0001147 |
| MousePheno | abnormal sex determination | RGPD4 RGPD2 FANCB RANBP2 BRIP1 RGPD8 BRCA2 FBXW12 RGPD3 AGPAT2 EIF2S2 RGPD1 LEPR | 8.40e-04 | 945 | 71 | 13 | MP:0002210 |
| MousePheno | increased organ/body region tumor incidence | 8.50e-04 | 395 | 71 | 8 | MP:0010274 | |
| MousePheno | embryonic lethality prior to organogenesis | RGPD4 MED20 RAB10 RGPD2 RANBP2 ERCC3 DCAF13 WAPL RGPD8 BRCA2 XPO5 FBXW12 RGPD3 EIF2S2 RGPD1 | 8.92e-04 | 1204 | 71 | 15 | MP:0013292 |
| MousePheno | abnormal organ/body region tumor incidence | 9.38e-04 | 401 | 71 | 8 | MP:0013152 | |
| MousePheno | abnormal susceptibility to weight gain | 9.55e-04 | 309 | 71 | 7 | MP:0011117 | |
| MousePheno | embryonic lethality between somite formation and embryo turning, complete penetrance | 9.90e-04 | 87 | 71 | 4 | MP:0011097 | |
| MousePheno | abnormal energy expenditure | 1.03e-03 | 313 | 71 | 7 | MP:0005450 | |
| MousePheno | abnormal energy homeostasis | 1.21e-03 | 322 | 71 | 7 | MP:0005448 | |
| MousePheno | neoplasm | RGPD4 RGPD2 RANBP2 BRIP1 RGPD8 BRCA2 PTPRJ RGPD3 EIF2S2 RGPD1 LEPR | 1.28e-03 | 747 | 71 | 11 | MP:0002006 |
| MousePheno | embryonic lethality prior to tooth bud stage | RGPD4 MED20 RAB10 RGPD2 TTBK2 RANBP2 ERCC3 DCAF13 WAPL RGPD8 BRCA2 XPO5 FBXW12 RGPD3 EIF2S2 RGPD1 | 1.29e-03 | 1383 | 71 | 16 | MP:0013293 |
| MousePheno | abnormal tumor incidence | RGPD4 RGPD2 RANBP2 BRIP1 RGPD8 BRCA2 PTPRJ RGPD3 EIF2S2 RGPD1 | 1.32e-03 | 635 | 71 | 10 | MP:0002019 |
| MousePheno | decreased primordial germ cell proliferation | 1.36e-03 | 11 | 71 | 2 | MP:0030934 | |
| MousePheno | abnormal internal male genitalia morphology | RGPD4 RGPD2 FANCB RANBP2 BRIP1 RGPD8 BRCA2 FBXW12 RGPD3 AGPAT2 EIF2S2 RGPD1 ERGIC2 GRIN3A LEPR SORL1 | 1.38e-03 | 1392 | 71 | 16 | MP:0009205 |
| MousePheno | increased tumor incidence | 1.39e-03 | 530 | 71 | 9 | MP:0002020 | |
| MousePheno | small gonad | RGPD4 RGPD2 FANCB RANBP2 BRIP1 RGPD8 BRCA2 FBXW12 RGPD3 AGPAT2 EIF2S2 RGPD1 | 1.54e-03 | 885 | 71 | 12 | MP:0001116 |
| MousePheno | abnormal tumor susceptibility | RGPD4 RGPD2 RANBP2 BRIP1 RGPD8 BRCA2 PTPRJ RGPD3 EIF2S2 RGPD1 | 1.57e-03 | 650 | 71 | 10 | MP:0002166 |
| MousePheno | abnormal lung morphology | RGPD4 RGPD2 DPP4 IFT140 RANBP2 RGPD8 COPA HECTD3 FBXW12 RGPD3 RGPD1 | 1.58e-03 | 767 | 71 | 11 | MP:0001175 |
| MousePheno | abnormal primordial germ cell proliferation | 1.62e-03 | 12 | 71 | 2 | MP:0008390 | |
| MousePheno | abnormal male genitalia morphology | RGPD4 RGPD2 FANCB RANBP2 BRIP1 RGPD8 BRCA2 FBXW12 RGPD3 AGPAT2 EIF2S2 RGPD1 ERGIC2 GRIN3A LEPR SORL1 | 1.64e-03 | 1415 | 71 | 16 | MP:0009198 |
| MousePheno | abnormal male reproductive system morphology | RGPD4 RGPD2 FANCB RANBP2 BRIP1 RGPD8 BRCA2 FBXW12 RGPD3 AGPAT2 EIF2S2 RGPD1 ERGIC2 GRIN3A LEPR SORL1 | 1.64e-03 | 1415 | 71 | 16 | MP:0001145 |
| MousePheno | abnormal pancreatic beta cell mass | 1.73e-03 | 47 | 71 | 3 | MP:0009112 | |
| MousePheno | abnormal male reproductive gland morphology | RGPD4 RGPD2 FANCB RANBP2 BRIP1 RGPD8 BRCA2 FBXW12 RGPD3 AGPAT2 EIF2S2 RGPD1 ERGIC2 LEPR SORL1 | 1.79e-03 | 1290 | 71 | 15 | MP:0013325 |
| MousePheno | abnormal respiratory system morphology | TBX22 RGPD4 RGPD2 DPP4 IFT140 RANBP2 RGPD8 COPA HECTD3 FBXW12 RGPD3 RGPD1 ANKH | 1.79e-03 | 1027 | 71 | 13 | MP:0002132 |
| MousePheno | abnormal primary sex determination | RGPD4 RGPD2 FANCB RANBP2 BRIP1 RGPD8 BRCA2 FBXW12 RGPD3 AGPAT2 EIF2S2 RGPD1 | 1.79e-03 | 901 | 71 | 12 | MP:0002211 |
| Domain | Ran_BP1 | 3.69e-14 | 12 | 90 | 7 | PF00638 | |
| Domain | RANBD1 | 3.69e-14 | 12 | 90 | 7 | PS50196 | |
| Domain | RanBD | 7.97e-14 | 13 | 90 | 7 | SM00160 | |
| Domain | Ran_bind_dom | 7.97e-14 | 13 | 90 | 7 | IPR000156 | |
| Domain | Grip | 4.79e-12 | 11 | 90 | 6 | SM00755 | |
| Domain | GRIP | 4.79e-12 | 11 | 90 | 6 | PF01465 | |
| Domain | GRIP_dom | 9.54e-12 | 12 | 90 | 6 | IPR000237 | |
| Domain | GRIP | 9.54e-12 | 12 | 90 | 6 | PS50913 | |
| Domain | GCC2_Rab_bind | 4.84e-11 | 7 | 90 | 5 | IPR032023 | |
| Domain | Rab_bind | 4.84e-11 | 7 | 90 | 5 | PF16704 | |
| Domain | - | 5.74e-10 | 10 | 90 | 5 | 1.10.220.60 | |
| Domain | TPR-contain_dom | 6.38e-07 | 150 | 90 | 8 | IPR013026 | |
| Domain | TPR_REGION | 1.31e-06 | 165 | 90 | 8 | PS50293 | |
| Domain | TPR | 1.31e-06 | 165 | 90 | 8 | PS50005 | |
| Domain | TPR-like_helical_dom | 1.67e-05 | 233 | 90 | 8 | IPR011990 | |
| Domain | TPR | 3.74e-05 | 129 | 90 | 6 | SM00028 | |
| Domain | TPR_repeat | 4.44e-05 | 133 | 90 | 6 | IPR019734 | |
| Domain | Ras | 5.03e-05 | 136 | 90 | 6 | PF00071 | |
| Domain | P-loop_NTPase | NDST3 RAB10 ERCC3 BRIP1 RAP2A RAP2B MYH13 SHPRH IFI44L GNAT1 CAMTA1 RAP2C RHOF RAB3C | 5.17e-05 | 848 | 90 | 14 | IPR027417 |
| Domain | Fatty_acid-bd | 5.79e-05 | 16 | 90 | 3 | IPR000463 | |
| Domain | FABP | 5.79e-05 | 16 | 90 | 3 | PS00214 | |
| Domain | iLBP | 5.79e-05 | 16 | 90 | 3 | IPR031259 | |
| Domain | Small_GTPase | 1.24e-04 | 160 | 90 | 6 | IPR001806 | |
| Domain | Small_GTP-bd_dom | 1.56e-04 | 167 | 90 | 6 | IPR005225 | |
| Domain | PH_dom-like | 2.12e-04 | 426 | 90 | 9 | IPR011993 | |
| Domain | - | NDST3 RAB10 ERCC3 BRIP1 RAP2A RAP2B SHPRH IFI44L GNAT1 RAP2C RHOF RAB3C | 2.37e-04 | 746 | 90 | 12 | 3.40.50.300 |
| Domain | APC_su10/DOC_dom | 4.75e-04 | 7 | 90 | 2 | IPR004939 | |
| Domain | DOC | 4.75e-04 | 7 | 90 | 2 | PS51284 | |
| Domain | APC10 | 4.75e-04 | 7 | 90 | 2 | SM01337 | |
| Domain | ANAPC10 | 4.75e-04 | 7 | 90 | 2 | PF03256 | |
| Domain | - | 4.95e-04 | 207 | 90 | 6 | 1.25.40.10 | |
| Domain | Lipocln_cytosolic_FA-bd_dom | 5.81e-04 | 34 | 90 | 3 | IPR000566 | |
| Domain | Lipocalin | 5.81e-04 | 34 | 90 | 3 | PF00061 | |
| Domain | - | 6.33e-04 | 35 | 90 | 3 | 2.40.128.20 | |
| Domain | RAS | 6.33e-04 | 35 | 90 | 3 | PS51421 | |
| Domain | Calycin | 7.47e-04 | 37 | 90 | 3 | IPR012674 | |
| Domain | Cadherin_tail | 7.47e-04 | 37 | 90 | 3 | PF15974 | |
| Domain | Small_GTPase_Ras | 7.47e-04 | 37 | 90 | 3 | IPR020849 | |
| Domain | Cadherin_CBD | 7.47e-04 | 37 | 90 | 3 | IPR031904 | |
| Domain | Calycin-like | 7.47e-04 | 37 | 90 | 3 | IPR011038 | |
| Domain | TPR_1 | 9.39e-04 | 90 | 90 | 4 | PF00515 | |
| Domain | TPR_1 | 9.39e-04 | 90 | 90 | 4 | IPR001440 | |
| Domain | Cadherin_CS | 1.91e-03 | 109 | 90 | 4 | IPR020894 | |
| Domain | CADHERIN_1 | 2.18e-03 | 113 | 90 | 4 | PS00232 | |
| Domain | Cadherin | 2.18e-03 | 113 | 90 | 4 | PF00028 | |
| Domain | CADHERIN_2 | 2.25e-03 | 114 | 90 | 4 | PS50268 | |
| Domain | - | 2.25e-03 | 114 | 90 | 4 | 2.60.40.60 | |
| Domain | CA | 2.32e-03 | 115 | 90 | 4 | SM00112 | |
| Domain | Cadherin-like | 2.39e-03 | 116 | 90 | 4 | IPR015919 | |
| Domain | Cadherin | 2.55e-03 | 118 | 90 | 4 | IPR002126 | |
| Domain | - | 2.81e-03 | 391 | 90 | 7 | 2.30.29.30 | |
| Domain | Cyclophilin-type_PPIase_CS | 3.72e-03 | 19 | 90 | 2 | IPR020892 | |
| Domain | Cadherin_2 | 3.81e-03 | 65 | 90 | 3 | PF08266 | |
| Domain | Cadherin_N | 3.81e-03 | 65 | 90 | 3 | IPR013164 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 3.54e-10 | 18 | 76 | 6 | MM1549 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 6.67e-08 | 40 | 76 | 6 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 7.78e-08 | 41 | 76 | 6 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 9.03e-08 | 42 | 76 | 6 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 1.05e-07 | 43 | 76 | 6 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.81e-07 | 47 | 76 | 6 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 2.34e-07 | 49 | 76 | 6 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 2.64e-07 | 50 | 76 | 6 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 2.98e-07 | 51 | 76 | 6 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 4.72e-07 | 55 | 76 | 6 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 6.51e-07 | 58 | 76 | 6 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 6.51e-07 | 58 | 76 | 6 | MM14736 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 1.29e-06 | 65 | 76 | 6 | MM15147 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 2.57e-06 | 73 | 76 | 6 | MM14948 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 5.09e-06 | 82 | 76 | 6 | MM15394 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 5.85e-06 | 84 | 76 | 6 | MM14929 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 5.91e-06 | 129 | 76 | 7 | MM14894 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 6.71e-06 | 86 | 76 | 6 | MM15413 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 9.92e-06 | 92 | 76 | 6 | MM14951 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 1.60e-05 | 100 | 76 | 6 | MM14561 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 3.38e-05 | 114 | 76 | 6 | MM15361 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 3.91e-05 | 117 | 76 | 6 | MM15387 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 7.96e-05 | 193 | 76 | 7 | MM14890 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 1.02e-04 | 271 | 76 | 8 | MM15388 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 1.02e-04 | 271 | 76 | 8 | MM15406 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 1.06e-04 | 202 | 76 | 7 | MM15362 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 1.11e-04 | 141 | 76 | 6 | MM15266 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | RAB10 RAP2B CRACR2A PTPRJ AGPAT2 CKAP4 FRMPD3 RAP2C RHOF DERA | 2.35e-04 | 478 | 76 | 10 | M27620 |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 2.62e-04 | 234 | 76 | 7 | MM14898 | |
| Pathway | REACTOME_SUMOYLATION | 2.97e-04 | 169 | 76 | 6 | MM14919 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | RAB10 RAP2B CRACR2A PTPRJ AGPAT2 CKAP4 FRMPD3 RAP2C RHOF DERA | 3.99e-04 | 511 | 76 | 10 | MM15330 |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | 1.53e-03 | 505 | 76 | 9 | MM15548 | |
| Pathway | REACTOME_TRIGLYCERIDE_CATABOLISM | 1.53e-03 | 11 | 76 | 2 | MM14629 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | RPS4Y2 RGPD4 RGPD2 RANBP2 ERCC3 DCAF13 RGPD8 RGPD3 RGPD1 DIS3 | 1.59e-03 | 612 | 76 | 10 | MM15547 |
| Pathway | PID_FANCONI_PATHWAY | 2.06e-03 | 47 | 76 | 3 | M1 | |
| Pubmed | 2.17e-15 | 7 | 93 | 6 | 9037092 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 2.17e-15 | 7 | 93 | 6 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 2.17e-15 | 7 | 93 | 6 | 11353387 | |
| Pubmed | 2.17e-15 | 7 | 93 | 6 | 30944974 | ||
| Pubmed | 2.17e-15 | 7 | 93 | 6 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 2.17e-15 | 7 | 93 | 6 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 2.17e-15 | 7 | 93 | 6 | 17372272 | |
| Pubmed | 2.17e-15 | 7 | 93 | 6 | 38657106 | ||
| Pubmed | 2.17e-15 | 7 | 93 | 6 | 21205196 | ||
| Pubmed | 2.17e-15 | 7 | 93 | 6 | 18949001 | ||
| Pubmed | 2.17e-15 | 7 | 93 | 6 | 25187515 | ||
| Pubmed | 2.17e-15 | 7 | 93 | 6 | 8603673 | ||
| Pubmed | 2.17e-15 | 7 | 93 | 6 | 26632511 | ||
| Pubmed | 2.17e-15 | 7 | 93 | 6 | 24403063 | ||
| Pubmed | 2.17e-15 | 7 | 93 | 6 | 23818861 | ||
| Pubmed | 2.17e-15 | 7 | 93 | 6 | 23536549 | ||
| Pubmed | 2.17e-15 | 7 | 93 | 6 | 12191015 | ||
| Pubmed | 2.17e-15 | 7 | 93 | 6 | 22821000 | ||
| Pubmed | 2.17e-15 | 7 | 93 | 6 | 20682751 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 8.65e-15 | 8 | 93 | 6 | 21670213 | |
| Pubmed | 8.65e-15 | 8 | 93 | 6 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 8.65e-15 | 8 | 93 | 6 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 8.65e-15 | 8 | 93 | 6 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 8.65e-15 | 8 | 93 | 6 | 28745977 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 2.59e-14 | 9 | 93 | 6 | 18394993 | |
| Pubmed | 2.59e-14 | 9 | 93 | 6 | 28100513 | ||
| Pubmed | 2.59e-14 | 9 | 93 | 6 | 17887960 | ||
| Pubmed | 2.59e-14 | 9 | 93 | 6 | 11553612 | ||
| Pubmed | 2.59e-14 | 9 | 93 | 6 | 10601307 | ||
| Pubmed | 2.59e-14 | 9 | 93 | 6 | 9733766 | ||
| Pubmed | 2.59e-14 | 9 | 93 | 6 | 28877029 | ||
| Pubmed | 6.46e-14 | 10 | 93 | 6 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 6.46e-14 | 10 | 93 | 6 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 6.46e-14 | 10 | 93 | 6 | 8857542 | |
| Pubmed | 6.46e-14 | 10 | 93 | 6 | 21859863 | ||
| Pubmed | 1.42e-13 | 11 | 93 | 6 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 1.42e-13 | 11 | 93 | 6 | 35771867 | |
| Pubmed | 1.42e-13 | 11 | 93 | 6 | 34110283 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 5.24e-13 | 13 | 93 | 6 | 31427429 | |
| Pubmed | 1.52e-12 | 15 | 93 | 6 | 14697343 | ||
| Pubmed | 2.24e-11 | 22 | 93 | 6 | 27717094 | ||
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 8.00e-10 | 38 | 93 | 6 | 12791264 | |
| Pubmed | 9.47e-09 | 99 | 93 | 7 | 27746211 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD4 RGPD2 FANCB TTBK2 RANBP2 WAPL PHF20 RGPD8 COPA RGPD3 RGPD1 ERGIC2 GNAT1 PPIB FABP3 RGPD5 | 6.81e-08 | 1155 | 93 | 16 | 20360068 |
| Pubmed | Rap2, but not Rap1 GTPase is expressed in human red blood cells and is involved in vesiculation. | 7.39e-08 | 4 | 93 | 3 | 16540189 | |
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 9480752 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | RAB10 DPP4 CRYZ RAP2B MYH13 PTPRJ VPS13C ACY3 SERPING1 CKAP4 RAP2C PPIB RHOF FABP3 SORL1 | 8.11e-08 | 1016 | 93 | 15 | 19056867 |
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 8.14e-08 | 135 | 93 | 7 | 31077711 | |
| Pubmed | 1.21e-07 | 215 | 93 | 8 | 35973513 | ||
| Pubmed | 1.23e-07 | 86 | 93 | 6 | 37253089 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.39e-07 | 146 | 93 | 7 | 23892456 | |
| Pubmed | Ubiquitylation by Rab40b/Cul5 regulates Rap2 localization and activity during cell migration. | 1.84e-07 | 5 | 93 | 3 | 35293963 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 6.94e-07 | 370 | 93 | 9 | 22922362 | |
| Pubmed | 1.90e-06 | 418 | 93 | 9 | 34709266 | ||
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 2.63e-06 | 226 | 93 | 7 | 37839992 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | RGPD4 MED20 RGPD2 ELOB RANBP2 RGPD8 COPA RGPD3 RGPD1 CKAP4 DIS3 | 2.81e-06 | 701 | 93 | 11 | 30196744 |
| Pubmed | 3.65e-06 | 453 | 93 | 9 | 29656893 | ||
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 3.65e-06 | 153 | 93 | 6 | 26365490 | |
| Pubmed | Fatty Acid Binding Protein 3 Is Involved in n-3 and n-6 PUFA transport in mouse trophoblasts. | 5.19e-06 | 13 | 93 | 3 | 25122651 | |
| Pubmed | RPS4Y2 RGPD4 RAB10 RGPD2 RANBP2 DCAF13 MYH13 RGPD8 COPA RGPD3 RGPD1 SIPA1L2 PPIB RAB3C RGPD5 | 6.39e-06 | 1442 | 93 | 15 | 35575683 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 30393019 | ||
| Pubmed | MD2 activation by direct AGE interaction drives inflammatory diabetic cardiomyopathy. | 7.07e-06 | 2 | 93 | 2 | 32358497 | |
| Pubmed | VPS13C regulates phospho-Rab10-mediated lysosomal function in human dopaminergic neurons. | 7.07e-06 | 2 | 93 | 2 | 38358348 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 36302455 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 16213650 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 15454399 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 8424780 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 27074266 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 37806092 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 27323829 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 21044951 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 34374497 | ||
| Pubmed | Rap2A links intestinal cell polarity to brush border formation. | 8.23e-06 | 15 | 93 | 3 | 22797597 | |
| Pubmed | 8.23e-06 | 15 | 93 | 3 | 15640798 | ||
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 9.88e-06 | 182 | 93 | 6 | 32239614 | |
| Pubmed | RGPD4 RAB10 RGPD2 RANBP2 RAP2B RGPD8 MYCBP2 RGPD3 RGPD1 FRMPD3 PPIB RAB3C | 1.01e-05 | 963 | 93 | 12 | 28671696 | |
| Pubmed | 1.22e-05 | 17 | 93 | 3 | 29911975 | ||
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | 1.47e-05 | 18 | 93 | 3 | 15570159 | |
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | 1.47e-05 | 18 | 93 | 3 | 10662547 | |
| Pubmed | RGPD4 RGPD2 ELOB TTBK2 RANBP2 RGPD8 RGPD3 RGPD1 CKAP4 PPIB RGPD5 | 1.61e-05 | 844 | 93 | 11 | 25963833 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 3036869 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 24293639 | ||
| Pubmed | Hypoxia regulates the expression of fatty acid-binding proteins in primary term human trophoblasts. | 2.12e-05 | 3 | 93 | 2 | 17826730 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 38777142 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 20332657 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 3045729 | ||
| Pubmed | Sex Hormone-Binding Globulin Reduction in Metabolic Disorders May Play a Role in NAFLD Development. | 2.12e-05 | 3 | 93 | 2 | 28359088 | |
| Pubmed | Rap2 function requires palmitoylation and recycling endosome localization. | 2.38e-05 | 21 | 93 | 3 | 19061864 | |
| Pubmed | 2.75e-05 | 22 | 93 | 3 | 35293576 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | RAB10 DPP4 CRYZ PTPRJ CD38 SHBG SERPING1 PPIB RHOF FABP4 FABP3 PMP2 | 2.85e-05 | 1070 | 93 | 12 | 23533145 |
| Pubmed | 3.15e-05 | 23 | 93 | 3 | 20301575 | ||
| Pubmed | 3.60e-05 | 24 | 93 | 3 | 24698270 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 3.79e-05 | 231 | 93 | 6 | 16452087 | |
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 28380328 | ||
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 25659033 | ||
| Pubmed | Developmental regulation of LR11 expression in murine brain. | 4.23e-05 | 4 | 93 | 2 | 9726247 | |
| Pubmed | Identification and characterization of potential effector molecules of the Ras-related GTPase Rap2. | 4.23e-05 | 4 | 93 | 2 | 10085114 | |
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 22396741 | ||
| Pubmed | Light deprivation reduces the severity of experimental diabetic retinopathy. | 4.23e-05 | 4 | 93 | 2 | 31978605 | |
| Pubmed | 4.23e-05 | 4 | 93 | 2 | 19011769 | ||
| Interaction | RGPD4 interactions | 4.88e-12 | 22 | 91 | 7 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 2.50e-11 | 27 | 91 | 7 | int:RGPD2 | |
| Interaction | RGPD8 interactions | 1.49e-09 | 74 | 91 | 8 | int:RGPD8 | |
| Interaction | RGPD3 interactions | 1.64e-09 | 47 | 91 | 7 | int:RGPD3 | |
| Interaction | RGPD1 interactions | 2.23e-09 | 49 | 91 | 7 | int:RGPD1 | |
| Interaction | RGPD5 interactions | 2.60e-07 | 96 | 91 | 7 | int:RGPD5 | |
| Interaction | RAB40B interactions | 3.61e-07 | 33 | 91 | 5 | int:RAB40B | |
| Interaction | NPIPB6 interactions | 1.13e-06 | 18 | 91 | 4 | int:NPIPB6 | |
| Interaction | FKBP2 interactions | 2.05e-06 | 83 | 91 | 6 | int:FKBP2 | |
| Interaction | RAN interactions | RGPD4 RGPD2 RANBP2 RGPD8 MYCBP2 XPO5 RGPD3 EIF2S2 RGPD1 DIS3 RGPD5 | 9.63e-06 | 475 | 91 | 11 | int:RAN |
| Interaction | RANBP2 interactions | 3.70e-05 | 361 | 91 | 9 | int:RANBP2 | |
| Interaction | NEMP1 interactions | 5.17e-05 | 89 | 91 | 5 | int:NEMP1 | |
| Cytoband | 2q13 | 3.67e-04 | 68 | 93 | 3 | 2q13 | |
| Cytoband | 2q12.3 | 5.41e-04 | 17 | 93 | 2 | 2q12.3 | |
| Cytoband | 5q31 | 1.69e-03 | 115 | 93 | 3 | 5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q31 | 2.77e-03 | 137 | 93 | 3 | chr9q31 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.61e-07 | 115 | 64 | 7 | 769 | |
| GeneFamily | Fatty acid binding protein family | 2.29e-05 | 16 | 64 | 3 | 550 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 4.62e-05 | 20 | 64 | 3 | 548 | |
| GeneFamily | RAS type GTPase family | 1.77e-04 | 31 | 64 | 3 | 389 | |
| GeneFamily | Clustered protocadherins | 1.51e-03 | 64 | 64 | 3 | 20 | |
| GeneFamily | DNA helicases | 1.62e-03 | 17 | 64 | 2 | 1167 | |
| GeneFamily | Cyclophilin peptidylprolyl isomerases | 2.03e-03 | 19 | 64 | 2 | 909 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.66e-03 | 394 | 64 | 6 | 471 | |
| GeneFamily | Olfactory receptors, family 9 | 2.97e-03 | 23 | 64 | 2 | 156 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 2.23e-11 | 33 | 93 | 7 | MM477 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 9.29e-09 | 43 | 93 | 6 | MM3857 | |
| Coexpression | MATHEW_FANCONI_ANEMIA_GENES | 6.99e-06 | 11 | 93 | 3 | M12972 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | 2.47e-05 | 435 | 93 | 9 | MM1221 | |
| Coexpression | SUZUKI_RESPONSE_TO_TSA | 3.39e-05 | 18 | 93 | 3 | M1680 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | 4.81e-05 | 474 | 93 | 9 | M40991 | |
| Coexpression | SMID_BREAST_CANCER_NORMAL_LIKE_UP | 5.74e-05 | 485 | 93 | 9 | M8513 | |
| Coexpression | GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP | 6.80e-05 | 194 | 93 | 6 | M6493 | |
| Coexpression | GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_DN | 7.40e-05 | 197 | 93 | 6 | M4540 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN | 7.82e-05 | 199 | 93 | 6 | M3445 | |
| Coexpression | GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN | 7.82e-05 | 199 | 93 | 6 | M5799 | |
| Coexpression | GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_WT_CD4_TCELL_UP | 8.04e-05 | 200 | 93 | 6 | M9886 | |
| Coexpression | GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN | 8.04e-05 | 200 | 93 | 6 | M7150 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP | 8.04e-05 | 200 | 93 | 6 | M5418 | |
| Coexpression | GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 8.04e-05 | 200 | 93 | 6 | M9136 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.13e-07 | 157 | 92 | 6 | 0ad242320ada7bcb9e29548d3050bf4fd3a07115 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.13e-07 | 157 | 92 | 6 | fe4c9556806203e57522d1986754ebe5a20aa2de | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.78e-06 | 176 | 92 | 6 | ea27e18407b8a13e8212830da859efeb8f158690 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.78e-06 | 176 | 92 | 6 | bfbab3c5b738b3b0b1540f2059d0245fbd8c0031 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-06 | 177 | 92 | 6 | f1efd9c3074d5635700fe7fbebf3dd0b1e0a84f1 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.96e-06 | 179 | 92 | 6 | ecea75c568911ff56939c9f67ab901497bd4356c | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-06 | 182 | 92 | 6 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | COVID-19_Mild-CD4+_T_activated|COVID-19_Mild / Disease condition and Cell class | 2.16e-06 | 182 | 92 | 6 | 877b6e611626628e709568747512f2827ebb2795 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-06 | 185 | 92 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-06 | 187 | 92 | 6 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.68e-06 | 189 | 92 | 6 | f0aaf2994d319a39877d2845eaab9f166adead4e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.85e-06 | 191 | 92 | 6 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | Macrophages-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 3.12e-06 | 194 | 92 | 6 | 543b856b0fd883550c8f14baeae08fb9bf1a7768 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.21e-06 | 195 | 92 | 6 | 6c354c38ee2965d37152ffdc86ba929ba2049c6a | |
| ToppCell | Control-Myeloid-TRAM1|Control / Disease group,lineage and cell class （2021.01.30） | 3.21e-06 | 195 | 92 | 6 | cc0d9caad279f15650d37f4e5508163c6712dfc1 | |
| ToppCell | Macrophages-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 3.21e-06 | 195 | 92 | 6 | 2af46e87947c16a7c2c367637e606cfbb8a78528 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.21e-06 | 195 | 92 | 6 | ec218ae03ebf8588996e86d6d9a8ea3cf71affaa | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.31e-06 | 196 | 92 | 6 | a7291291931f9e5abd6a54349bc920a0ab68a4cb | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.50e-05 | 150 | 92 | 5 | 6c39e73a0b05d4b26589f333ce13924e3d373b8d | |
| ToppCell | frontal_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.60e-05 | 152 | 92 | 5 | f9c29d4568402ca07a717dbffb3ccc7f35c5fe56 | |
| ToppCell | Control-Myeloid-Neutrophils|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-05 | 153 | 92 | 5 | c33d63b2d1a220bc428e776b157b23faa43ea8ca | |
| ToppCell | Control-Myeloid-Neutrophils-Neutrophils|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-05 | 153 | 92 | 5 | e3630f2b10f33092a3b6a63dba3a39fbdecbc7bd | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.05e-05 | 160 | 92 | 5 | ac3f56f8ab8efd11c4b4868a828db05c23ac762f | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.30e-05 | 164 | 92 | 5 | 11dfd84f5fb90de330858e1e852848832734e004 | |
| ToppCell | 10x5'-GI_small-bowel-Mast|GI_small-bowel / Manually curated celltypes from each tissue | 3.06e-05 | 174 | 92 | 5 | e94c980b25edfd0e8598c416828801fcc00e8ead | |
| ToppCell | 10x5'-GI_small-bowel-Mast-Mast_cells|GI_small-bowel / Manually curated celltypes from each tissue | 3.06e-05 | 174 | 92 | 5 | 05525bf0a2bde2be4f7c147b17a24530ce8819e0 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-erythroid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.32e-05 | 177 | 92 | 5 | b647667da62a91dbe3890820142626e26aa779d2 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-05 | 177 | 92 | 5 | 14fb8d182775dfd0e49aa7e4e12543a85b3b8bd6 | |
| ToppCell | Control-Lymphocytic_NKT-T_cells-T-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.41e-05 | 178 | 92 | 5 | 910f8bea19d335455aba24e6a07b4834b709db5d | |
| ToppCell | Control-Lymphocytic_NKT-T_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.50e-05 | 179 | 92 | 5 | d892d9496f1c33e23312092591eb2e968e736f7d | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.60e-05 | 180 | 92 | 5 | fb8bc639f7f94e7aed9f9d708d5d5c78178533ae | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-B_cells-CLP|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.69e-05 | 181 | 92 | 5 | 1110a0375189c034e6b02e6ebceb7084e4590114 | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 3.79e-05 | 182 | 92 | 5 | 9adf90bb2808f234d53b89ca0ae07380478204ad | |
| ToppCell | RA-17._Lymphocyte|RA / Chamber and Cluster_Paper | 3.79e-05 | 182 | 92 | 5 | 257a7847917b6ea1d60608183d90300bfd028758 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.79e-05 | 182 | 92 | 5 | 1aea96ee211f7b9caef7fd385233f51be6021a73 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.79e-05 | 182 | 92 | 5 | b427e43ee523a3ea9eca3207f3d82042f10f022a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.79e-05 | 182 | 92 | 5 | c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.79e-05 | 182 | 92 | 5 | 4cb182ef39be2044a6ad7266f332d4177591e550 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Mild / Disease group, lineage and cell class | 3.89e-05 | 183 | 92 | 5 | 7717fce227b4e02ed41baad8ae7dd2e22bd7c13e | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 3.89e-05 | 183 | 92 | 5 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.89e-05 | 183 | 92 | 5 | e3ffef2b57dc5b96466dccc9cd54ba326ccf378a | |
| ToppCell | Control-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.89e-05 | 183 | 92 | 5 | 2c5707ada3442eb7100a2a5f9438d5a2ac53a9e1 | |
| ToppCell | 15-Distal-Immune-Hematopoietic,_B_Cells|Distal / Age, Tissue, Lineage and Cell class | 3.99e-05 | 184 | 92 | 5 | c294cd421f277992b56ae9c40b8f3948e33148fe | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.10e-05 | 185 | 92 | 5 | 08fad1e3c3cc5f1c3eb6629a49c094b628e75a92 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 4.21e-05 | 186 | 92 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | (4)_Lymph_vessel|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 4.21e-05 | 186 | 92 | 5 | 6b3afc2ae870ff73e30a60ce84fcee0eb365d809 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.42e-05 | 188 | 92 | 5 | 0501a8aa850bd2e347020abd1cac4d8075738189 | |
| ToppCell | LPS_only-Lymphocytic_NKT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.42e-05 | 188 | 92 | 5 | bbe65b1c11c88ab62d8485cfc3a913ff9da89aad | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_migrating_dendritic_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.54e-05 | 189 | 92 | 5 | 35380ca9409206e82528bde4f3795057b015278a | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-Activated_T|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.54e-05 | 189 | 92 | 5 | c38157c8cf5c0c1f560011ef5cc5892a049ee2b7 | |
| ToppCell | tumor_Lung-B_lymphocytes-GC_B_cells_in_the_LZ|B_lymphocytes / Location, Cell class and cell subclass | 4.65e-05 | 190 | 92 | 5 | bfb16efb23add53eebabc8e48f20c96994ec01da | |
| ToppCell | 343B-Endothelial_cells-Endothelial-A_(Artery)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.65e-05 | 190 | 92 | 5 | ac2eb1e51459d187095152e0cd41ae54c1025c6f | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Erythrophagocytic_macrophages|bone_marrow / Manually curated celltypes from each tissue | 4.65e-05 | 190 | 92 | 5 | 9db04555c98eca1df15d144fbb499e0ba06660d5 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-A_(Artery)|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.65e-05 | 190 | 92 | 5 | 6010f16378f2d9cde37c7e7db6a7d9666edaddcc | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.77e-05 | 191 | 92 | 5 | a05e9a7eb137d804570dd7d8905975d735738767 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.77e-05 | 191 | 92 | 5 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.77e-05 | 191 | 92 | 5 | fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b | |
| ToppCell | Control-B_intermediate-14|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.77e-05 | 191 | 92 | 5 | 076302fd247aab6c0b187ac9e0c67a3ba46414ba | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 4.89e-05 | 192 | 92 | 5 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175|Adult / Lineage, Cell type, age group and donor | 4.89e-05 | 192 | 92 | 5 | 733491e932350e3c216a626cc49c3cd3fe970a82 | |
| ToppCell | BAL-Mild|BAL / Compartment, Disease Groups and Clusters | 4.89e-05 | 192 | 92 | 5 | 1a6cbf014d3f7a3fb6f53adab078c4742e7137de | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.89e-05 | 192 | 92 | 5 | 0afb9dbe468e0be442c326e11c5fc0f699b32f23 | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 5.01e-05 | 193 | 92 | 5 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_natural_killer_[NK]_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.01e-05 | 193 | 92 | 5 | 1a22bfc704d8d6d108215f17f03bdf56f46bf8cf | |
| ToppCell | PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.14e-05 | 194 | 92 | 5 | b88cb13c4819e6462bb306d2302b737d3848711f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.14e-05 | 194 | 92 | 5 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-05 | 194 | 92 | 5 | e8102c8811333f04de7280b7d9b6b85cebb815ac | |
| ToppCell | (4)_Endothelial_cells-(4)_Lymph_vessel|(4)_Endothelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 5.14e-05 | 194 | 92 | 5 | 9735b86d3b2480a0b34d8aab8e7bd609d83c2454 | |
| ToppCell | Monocytes-Phagocytic_CD16+_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 5.14e-05 | 194 | 92 | 5 | 40dbfdf1d7e6b73d120d8f802f08e573fe9a739e | |
| ToppCell | PCW_13-14-Immune_Lymphocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.14e-05 | 194 | 92 | 5 | 36678999d0c1c5b0aab206fec7a8c36a0f43c56a | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-05 | 194 | 92 | 5 | 4b0d63babb8a46ff45731d5f82b29ccaf6c9402d | |
| ToppCell | COPD-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 5.26e-05 | 195 | 92 | 5 | e91ce548ae7224661ee5d2f2639794a5f69798ee | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.26e-05 | 195 | 92 | 5 | 1c1135be421af98cd0077bec1ff2c4158d42aa21 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.26e-05 | 195 | 92 | 5 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor3_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.26e-05 | 195 | 92 | 5 | c707885d092aedbbe14f51f7de4a5911c9214289 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor2_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.26e-05 | 195 | 92 | 5 | 799992721369357484300fe218aff075154c3148 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.26e-05 | 195 | 92 | 5 | 11d421bbbb71425d59cbdd673e052e00d5f0a768 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.26e-05 | 195 | 92 | 5 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | NS-moderate-d_16-33-Myeloid-Monocyte-derived_Macrophage|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.26e-05 | 195 | 92 | 5 | d87c83d2d421c9291d0a10bc9db850e9fb337667 | |
| ToppCell | Macrophages-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 5.26e-05 | 195 | 92 | 5 | e48bf57e6da23fbb4637a02387155f825455c49f | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.26e-05 | 195 | 92 | 5 | 1f005ee1da66b539bd200aaa98f46edbbc7f12e4 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.26e-05 | 195 | 92 | 5 | 10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.39e-05 | 196 | 92 | 5 | 05d17d7c6eb1f3e706eb0c4fbc4b4ac0a3aa3dd4 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_proliferating_myeloid_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.39e-05 | 196 | 92 | 5 | 3fd5567ea14193181929134c377e8a38fb4f47fd | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.39e-05 | 196 | 92 | 5 | ce3709adbde7559b40c964888935914f66003247 | |
| ToppCell | (7)_Macrophage|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 5.39e-05 | 196 | 92 | 5 | f1c822860d2a0bae84b0263b0151185756423e0f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.39e-05 | 196 | 92 | 5 | e54c08f88779f9fd453a4f5b85aed1f460d8a1e1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.52e-05 | 197 | 92 | 5 | 0a22686d586c0334a2fd872a28e26b75693234cf | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_ACKR1+_endothelial_cells|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.52e-05 | 197 | 92 | 5 | 143607d195c8aa2b94d995af0b2ef38582565611 | |
| ToppCell | (4)_Endothelial_cells|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 5.52e-05 | 197 | 92 | 5 | dd9abb43c23e7698433e455eacbf5b23b0a756c2 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.52e-05 | 197 | 92 | 5 | 2e622d75fb45cfa80f78e1880ad056a50709895a | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-TRAM-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 5.52e-05 | 197 | 92 | 5 | eecb693367510da20a6b1e9355e68785a1e3b85c | |
| ToppCell | severe-Others-Megakaryocytes|Others / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.52e-05 | 197 | 92 | 5 | fc0864e2de2d9f99084586b467551b6da535d933 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.66e-05 | 198 | 92 | 5 | e125eb8aa57c172e5518874da1bd25998292f5e2 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.66e-05 | 198 | 92 | 5 | 0baeb8e2c199ff10bb5c829c523546af3c9227c1 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.66e-05 | 198 | 92 | 5 | 75e3600ade0f1fa763189672b2d936f5b04bb606 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Lymphocytic-Lymphocytic_NK/T|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.66e-05 | 198 | 92 | 5 | a07590c6aa2c889b5d1a0413a6fba5b75bf5d70a | |
| ToppCell | COVID-19_Severe-Neu_1|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients | 5.66e-05 | 198 | 92 | 5 | bbe639ea5a636c985e509fb0a133ae3b60afac5a | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.66e-05 | 198 | 92 | 5 | 4aefab395df49b9f434d27104fecf64555e1c0b4 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.66e-05 | 198 | 92 | 5 | 3dafa555bd01e6d4b5ffbcdd542d738905140801 | |
| Drug | 2-(9-anthroyloxy)palmitate | 6.60e-08 | 3 | 93 | 3 | CID006455527 | |
| Disease | Fanconi anemia | 9.11e-06 | 14 | 88 | 3 | cv:C0015625 | |
| Disease | Bone marrow hypocellularity | 2.02e-05 | 18 | 88 | 3 | C1855710 | |
| Disease | Down syndrome (is_marker_for) | 3.79e-05 | 22 | 88 | 3 | DOID:14250 (is_marker_for) | |
| Disease | Fanconi Anemia | 5.62e-05 | 25 | 88 | 3 | C0015625 | |
| Disease | neutrophil count, basophil count | 5.77e-05 | 224 | 88 | 6 | EFO_0004833, EFO_0005090 | |
| Disease | Pancytopenia | 6.34e-05 | 26 | 88 | 3 | C0030312 | |
| Disease | Miller Dieker syndrome | 8.85e-05 | 29 | 88 | 3 | C0265219 | |
| Disease | worry measurement | 1.00e-04 | 154 | 88 | 5 | EFO_0009589 | |
| Disease | Abnormality of radial ray | 1.31e-04 | 33 | 88 | 3 | C4228778 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 1.64e-04 | 171 | 88 | 5 | DOID:9352 (is_implicated_in) | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 2.52e-04 | 41 | 88 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 2.52e-04 | 41 | 88 | 3 | C0858252 | |
| Disease | platelet measurement | 3.67e-04 | 315 | 88 | 6 | EFO_0005036 | |
| Disease | Erectile dysfunction | 3.90e-04 | 10 | 88 | 2 | C0242350 | |
| Disease | periodontitis | 5.55e-04 | 223 | 88 | 5 | EFO_0000649 | |
| Disease | alcohol and nicotine codependence | 6.71e-04 | 13 | 88 | 2 | EFO_0004776 | |
| Disease | sleep duration | 7.61e-04 | 362 | 88 | 6 | EFO_0005271 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 7.82e-04 | 14 | 88 | 2 | C0677776 | |
| Disease | glucose measurement | 9.78e-04 | 380 | 88 | 6 | EFO_0004468 | |
| Disease | MYELODYSPLASTIC SYNDROME | 1.07e-03 | 67 | 88 | 3 | C3463824 | |
| Disease | Malignant neoplasm of breast | SLC8A3 ERCC3 BRIP1 BRCA2 EIF2S2 SIX4 LEPR INPP4B FABP4 SORL1 | 1.35e-03 | 1074 | 88 | 10 | C0006142 |
| Disease | Pancreatic carcinoma | 1.45e-03 | 19 | 88 | 2 | C0235974 | |
| Disease | BREAST CANCER | 1.78e-03 | 21 | 88 | 2 | 114480 | |
| Disease | platelet component distribution width | 1.88e-03 | 755 | 88 | 8 | EFO_0007984 | |
| Disease | diet measurement, HOMA-IR | 2.14e-03 | 23 | 88 | 2 | EFO_0004501, EFO_0008111 | |
| Disease | visceral adipose tissue measurement, body mass index | 2.27e-03 | 87 | 88 | 3 | EFO_0004340, EFO_0004765 | |
| Disease | Albuminuria | 2.33e-03 | 24 | 88 | 2 | C0001925 | |
| Disease | pseudotumor cerebri | 2.73e-03 | 26 | 88 | 2 | EFO_1001132 | |
| Disease | Acute monocytic leukemia | 2.73e-03 | 26 | 88 | 2 | C0023465 | |
| Disease | Malignant tumor of breast | 2.94e-03 | 27 | 88 | 2 | cv:C0006142 | |
| Disease | Breast neoplasm | 2.94e-03 | 27 | 88 | 2 | cv:C1458155 | |
| Disease | Familial cancer of breast | 2.94e-03 | 27 | 88 | 2 | cv:C0346153 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SFSFTTVLTKEIKTE | 521 | Q9Y6Y1 | |
| KGVAFVQTEKFTFTV | 291 | Q96HD9 | |
| KVQSLQATFGTFESI | 161 | Q07065 | |
| FSENVDSLTSFKSIK | 71 | Q6ULP2 | |
| QDVIFKSAFKSTSTA | 141 | Q96RQ1 | |
| FKIVFVGNSAVGKTS | 546 | Q9BSW2 | |
| GTSFFTVGDDKTVKQ | 121 | Q9NV06 | |
| SRSKIFDKNSTFGSV | 211 | P28907 | |
| VIGFHKTSEKSVQSF | 161 | O95803 | |
| TTFISTIGIDFKIKT | 36 | P61026 | |
| FGSESVKSIFSSEKS | 2516 | P49792 | |
| KSALTVQFVTGTFIE | 16 | P10114 | |
| KSALTVQFVTGSFIE | 16 | P61225 | |
| KSALTVQFVTGTFIE | 16 | Q9Y3L5 | |
| ETTEDTIKKSFGQFN | 256 | A0AV96 | |
| GFINSSIITKKTFSF | 151 | Q8NH87 | |
| TSAFVSTVGIDFKVK | 56 | Q96E17 | |
| AFKKGDRVFTSSTIS | 86 | Q08257 | |
| SSNTEFKSTKEGFSI | 901 | Q99666 | |
| SSNTEFKSTKEGFSI | 901 | O14715 | |
| IQTSTGKVFSVIASF | 926 | P48200 | |
| TNSQIDKSDFITFGK | 891 | Q9UN72 | |
| TSVSHNSVKVKFSGF | 826 | Q12913 | |
| FSTVFQVPSTKSLFK | 221 | Q9Y585 | |
| KTTGIIETQFSFKDL | 176 | P11488 | |
| VGSGKSSFFNSVKSI | 206 | Q53G44 | |
| FKSSSSKGEKTLEFV | 326 | O15327 | |
| STFKNTEISFKLGVE | 56 | P05413 | |
| SQSSTGKKTEFITFD | 301 | Q6X9E4 | |
| FITFDLTTKKTGGQT | 311 | Q6X9E4 | |
| NNTFFSKTETITTEK | 16 | P34910 | |
| FTVTKFDKQGNVTSF | 86 | Q9HD23 | |
| IEGKTFVSTVNSLVF | 106 | P48357 | |
| VKFFVVNTDSLSSVT | 266 | P27487 | |
| GFINSSIITKKTFSF | 151 | P0C7N8 | |
| RVGTKKTSFVNFTDI | 211 | P20042 | |
| TTQTGSVKFEDFVTA | 111 | Q9NZI2 | |
| VKGSTIVSSENNFFI | 451 | Q8TCU5 | |
| VFVQKSTGFFTIKEE | 56 | Q8NB91 | |
| FFISSQTGKVVSVSG | 151 | Q8NB91 | |
| KSFSSELGVTFTIQL | 621 | Q9BX63 | |
| TNSQIDKSDFITFGK | 961 | Q9Y5I4 | |
| TNSQIDKSDFITFGK | 901 | Q9UN74 | |
| FGSESVKRIFSSEKS | 1541 | A6NKT7 | |
| KSAEGFFVLNKSTTI | 6 | B1AJZ9 | |
| GLAKTAATVFSKSFE | 441 | Q9BYI3 | |
| FKTITSAATAFVKTG | 1796 | Q9Y2F5 | |
| FKTSTLSVSSFFKQE | 461 | Q8NF50 | |
| DISSISIFTGIKEFK | 286 | Q9UBT7 | |
| TFFQTASGKNISVAK | 1426 | P51587 | |
| KTTIFTDAKESSTVF | 11 | Q15370 | |
| LTVSKGFFEGTIASK | 811 | P53621 | |
| IKSFTFDGRTTVKDV | 191 | Q5JV73 | |
| LGTIFSFISKDVVSK | 46 | Q5TA50 | |
| KTITVTFFNGDVKQV | 1186 | Q9HC77 | |
| VESTAKKFFTVDSST | 1816 | Q8TDW7 | |
| KKFFTVDSSTGAIRT | 1821 | Q8TDW7 | |
| SNTVTAAHIKKFTFV | 316 | Q9HCJ1 | |
| TAFVKFSTLTKELST | 116 | Q9ULH1 | |
| LKTTQFSGTLGEKFE | 26 | A8MUU1 | |
| KGFTTKGVTSVSQIF | 211 | P05155 | |
| ETVNTTISFSFKGIK | 111 | Q9Y6Y9 | |
| TIKSESTFKNTEISF | 51 | P15090 | |
| KINTIFISKVGDTSF | 601 | P19447 | |
| FIKTSTGKETVNATF | 216 | Q9Y315 | |
| SISGKVQTATFQVFV | 111 | Q9BZW8 | |
| LKSGDTEKITFFASV | 1226 | Q96RY7 | |
| YNTKKKFFTSGTVTV | 211 | O15120 | |
| KFFTSGTVTVQVLEA | 216 | O15120 | |
| SSNTEFKSTKEGFSI | 886 | P0DJD0 | |
| FFQSAKASKIETRGT | 101 | Q9H944 | |
| VEVTNTFKKTDDFGS | 426 | Q9BVI0 | |
| FGSESVKRIFSSEKS | 1541 | Q7Z3J3 | |
| SVFEKYTASVTVGSK | 51 | Q9HBH0 | |
| GEKSTVFTIFGSNKE | 591 | Q92673 | |
| LFTSVFGVGLKTSEK | 251 | P04053 | |
| NTEFKSTKEGFSIAV | 896 | P0DJD1 | |
| DTNGSQFFITTVKTA | 146 | P23284 | |
| FDLTKITKTSSSFEV | 61 | P04278 | |
| TVDTSVKFSFITLGA | 821 | Q9P2F8 | |
| FTSESTTVQQGKVFL | 531 | Q9UIU6 | |
| KLFSNTVKGQTAIFE | 1256 | Q149N8 | |
| TGKITSFIKFDTGNV | 166 | Q8TD47 | |
| SITTDDGVVFQFKSS | 1351 | O75592 | |
| SVSKAKFAAGSVVSF | 2096 | Q4LDE5 | |
| TQLFFKSKGIVSEEA | 836 | Q9Y2L1 | |
| TKFTKEETSSLATVF | 391 | Q14246 | |
| SITKVKQFEGSTSFV | 61 | Q8NFX7 | |
| GKVRSNVFSTKFTIF | 351 | O00295 | |
| VKTFSFKETEFTTVT | 246 | Q9Y458 | |
| LTSVFDNSIKTFGVI | 276 | Q6IQ55 | |
| KLFSSVTFETVEESK | 576 | Q9HAV4 | |
| GSSKFDEVFSNKRTT | 16 | Q7Z5K2 | |
| GKKKGSSFQTVSAVF | 641 | Q9UKX3 | |
| QTAFGKTEQTVKVAF | 1006 | Q709C8 | |
| TAAFSNVGTAISKKF | 111 | Q16890 | |
| EFKFGKELTFTTVLS | 661 | Q5T447 | |
| KDSVTAVVFVAFGTS | 786 | P57103 | |
| STFKNTEISFKLGQE | 56 | P02689 |